Global Personal Lancets Market

Personal Lancets Comprehensive Study by Type (21G, 26G, 28G, 30G, 33G, Others), Application (Glucose Testing, Hemoglobin Testing, Coagulation Testing, Other Applications), Distribution Channel (Online, Offline), Material Type (Natural Plastic, Latex-Free Plastic) Players and Region - Global Market Outlook to 2030

Personal Lancets Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Personal Lancets Market Scope
Lancets are used for diabetes/glucose testing, baby testing, heel pin screening, and scarred emergency or severely burned patients. Personal lancets should be used by laypeople with a lancing device to collect capillary blood. Pricking your fingers is an integral part of blood sugar self-monitoring and part of everyday life for millions of people with diabetes. A small finger prick followed by a drop of blood on the test strip allows people to see blood sugar levels within seconds. This helps patients identify symptoms of hypo- / hyperglycemia and prevent long-term complications from diabetes. Factors driving market growth include the incidence of infectious and non-contagious diseases, the prevalence of diabetes, and the tendency towards home treatment and diagnosis. However, the risk associated with blood transfusions is likely to hamper market development during the forecast period.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
Key Companies ProfiledBecton, Dickinson, and Company (United States), Roche Diagnostics (Switzerland), Ypsomed (Switzerland), B. Braun Melsungen (Germany), Terumo Corporation (Japan), Own Mumford (United Kingdom), HTL-STREFA S.A (Poland) and ARKRAY (Japan)
CAGR%


The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Personal Lancets market throughout the predicted period.

Becton, Dickinson, and Company (United States), Roche Diagnostics (Switzerland), Ypsomed (Switzerland), B. Braun Melsungen (Germany), Terumo Corporation (Japan), Own Mumford (United Kingdom), HTL-STREFA S.A (Poland) and ARKRAY (Japan) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Sarstedt (Germany) and SteriLance Medical (Suzhou) (China).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Personal Lancets market by Type , by Application (Glucose Testing, Hemoglobin Testing, Coagulation Testing and Other Applications) and Region with country level break-up.

On the basis of geography, the market of Personal Lancets has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2023.

Market Leaders and their expansionary development strategies
In 2018, HTL-STREFA was acquired by Investindustrial. This acquisition helped the companies partner for diabetes management, thus serving an extensive customer base.
In 2018, HTL-STREFA expanded its storage capacity in Leczyca by almost 50%, with an equivalent of 3,550 m2 additional storage space.


Influencing Trend:
The Rising Adoption of Push-Button Safety Lancets due to the Efficient Retraction of the Sample with the Push of a Single Button will Foster their Demand

Market Growth Drivers:
Monitoring of diabetes in the diabetic community is one of the main uses or working fields of lancets. According to the Centers for Disease Control and Prevention ( CDC), diabetic patients account for 9.4 percent of the US population. The need for lancets is projected to be tremendous with the growing prevalence of diabetes, resulting in a rising need for diabetes detection and management equipment and products, potentially leading to expanded use of lancets.

Challenges:
Reuse of Lancets

Restraints:
Risk of Needlestick Injuries and Poor Reimbursement Scenario in Developing Countries

Opportunities:
High Growth Prospects in Emerging Countries and High Prevalence of Anemia Expected to Increase Hemoglobin Testing Volume and the Demand for Lancets

Key Target Audience
Providers of Personal Lancets, End-Users, Potential Investors, Market Research Firms and Others

Report Objectives / Segmentation Covered

By Type
  • 21G
  • 26G
  • 28G
  • 30G
  • 33G
  • Others
By Application
  • Glucose Testing
  • Hemoglobin Testing
  • Coagulation Testing
  • Other Applications
By Distribution Channel
  • Online
  • Offline

By Material Type
  • Natural Plastic
  • Latex-Free Plastic

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Monitoring of diabetes in the diabetic community is one of the main uses or working fields of lancets. According to the Centers for Disease Control and Prevention ( CDC), diabetic patients account for 9.4 percent of the US population. The need for lancets is projected to be tremendous with the growing prevalence of diabetes, resulting in a rising need for diabetes detection and management equipment and products, potentially leading to expanded use of lancets.
    • 3.3. Market Challenges
      • 3.3.1. Reuse of Lancets
    • 3.4. Market Trends
      • 3.4.1. The Rising Adoption of Push-Button Safety Lancets due to the Efficient Retraction of the Sample with the Push of a Single Button will Foster their Demand
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Personal Lancets, by Type, Application, Distribution Channel, Material Type and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Personal Lancets (Value)
      • 5.2.1. Global Personal Lancets by: Type (Value)
        • 5.2.1.1. 21G
        • 5.2.1.2. 26G
        • 5.2.1.3. 28G
        • 5.2.1.4. 30G
        • 5.2.1.5. 33G
        • 5.2.1.6. Others
      • 5.2.2. Global Personal Lancets by: Application (Value)
        • 5.2.2.1. Glucose Testing
        • 5.2.2.2. Hemoglobin Testing
        • 5.2.2.3. Coagulation Testing
        • 5.2.2.4. Other Applications
      • 5.2.3. Global Personal Lancets by: Distribution Channel (Value)
        • 5.2.3.1. Online
        • 5.2.3.2. Offline
      • 5.2.4. Global Personal Lancets by: Material Type (Value)
        • 5.2.4.1. Natural Plastic
        • 5.2.4.2. Latex-Free Plastic
      • 5.2.5. Global Personal Lancets Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Personal Lancets (Volume)
      • 5.3.1. Global Personal Lancets by: Type (Volume)
        • 5.3.1.1. 21G
        • 5.3.1.2. 26G
        • 5.3.1.3. 28G
        • 5.3.1.4. 30G
        • 5.3.1.5. 33G
        • 5.3.1.6. Others
      • 5.3.2. Global Personal Lancets by: Application (Volume)
        • 5.3.2.1. Glucose Testing
        • 5.3.2.2. Hemoglobin Testing
        • 5.3.2.3. Coagulation Testing
        • 5.3.2.4. Other Applications
      • 5.3.3. Global Personal Lancets by: Distribution Channel (Volume)
        • 5.3.3.1. Online
        • 5.3.3.2. Offline
      • 5.3.4. Global Personal Lancets by: Material Type (Volume)
        • 5.3.4.1. Natural Plastic
        • 5.3.4.2. Latex-Free Plastic
      • 5.3.5. Global Personal Lancets Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Personal Lancets (Price)
      • 5.4.1. Global Personal Lancets by: Type (Price)
  • 6. Personal Lancets: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Becton, Dickinson, and Company (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Roche Diagnostics (Switzerland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Ypsomed (Switzerland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. B. Braun Melsungen (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Terumo Corporation (Japan)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Own Mumford (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. HTL-STREFA S.A (Poland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. ARKRAY (Japan)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Personal Lancets Sale, by Type, Application, Distribution Channel, Material Type and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Personal Lancets (Value)
      • 7.2.1. Global Personal Lancets by: Type (Value)
        • 7.2.1.1. 21G
        • 7.2.1.2. 26G
        • 7.2.1.3. 28G
        • 7.2.1.4. 30G
        • 7.2.1.5. 33G
        • 7.2.1.6. Others
      • 7.2.2. Global Personal Lancets by: Application (Value)
        • 7.2.2.1. Glucose Testing
        • 7.2.2.2. Hemoglobin Testing
        • 7.2.2.3. Coagulation Testing
        • 7.2.2.4. Other Applications
      • 7.2.3. Global Personal Lancets by: Distribution Channel (Value)
        • 7.2.3.1. Online
        • 7.2.3.2. Offline
      • 7.2.4. Global Personal Lancets by: Material Type (Value)
        • 7.2.4.1. Natural Plastic
        • 7.2.4.2. Latex-Free Plastic
      • 7.2.5. Global Personal Lancets Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Personal Lancets (Volume)
      • 7.3.1. Global Personal Lancets by: Type (Volume)
        • 7.3.1.1. 21G
        • 7.3.1.2. 26G
        • 7.3.1.3. 28G
        • 7.3.1.4. 30G
        • 7.3.1.5. 33G
        • 7.3.1.6. Others
      • 7.3.2. Global Personal Lancets by: Application (Volume)
        • 7.3.2.1. Glucose Testing
        • 7.3.2.2. Hemoglobin Testing
        • 7.3.2.3. Coagulation Testing
        • 7.3.2.4. Other Applications
      • 7.3.3. Global Personal Lancets by: Distribution Channel (Volume)
        • 7.3.3.1. Online
        • 7.3.3.2. Offline
      • 7.3.4. Global Personal Lancets by: Material Type (Volume)
        • 7.3.4.1. Natural Plastic
        • 7.3.4.2. Latex-Free Plastic
      • 7.3.5. Global Personal Lancets Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Personal Lancets (Price)
      • 7.4.1. Global Personal Lancets by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Personal Lancets: by Type(USD Million)
  • Table 2. Personal Lancets 21G , by Region USD Million (2018-2023)
  • Table 3. Personal Lancets 26G , by Region USD Million (2018-2023)
  • Table 4. Personal Lancets 28G , by Region USD Million (2018-2023)
  • Table 5. Personal Lancets 30G , by Region USD Million (2018-2023)
  • Table 6. Personal Lancets 33G , by Region USD Million (2018-2023)
  • Table 7. Personal Lancets Others , by Region USD Million (2018-2023)
  • Table 8. Personal Lancets: by Application(USD Million)
  • Table 9. Personal Lancets Glucose Testing , by Region USD Million (2018-2023)
  • Table 10. Personal Lancets Hemoglobin Testing , by Region USD Million (2018-2023)
  • Table 11. Personal Lancets Coagulation Testing , by Region USD Million (2018-2023)
  • Table 12. Personal Lancets Other Applications , by Region USD Million (2018-2023)
  • Table 13. Personal Lancets: by Distribution Channel(USD Million)
  • Table 14. Personal Lancets Online , by Region USD Million (2018-2023)
  • Table 15. Personal Lancets Offline , by Region USD Million (2018-2023)
  • Table 16. Personal Lancets: by Material Type(USD Million)
  • Table 17. Personal Lancets Natural Plastic , by Region USD Million (2018-2023)
  • Table 18. Personal Lancets Latex-Free Plastic , by Region USD Million (2018-2023)
  • Table 19. South America Personal Lancets, by Country USD Million (2018-2023)
  • Table 20. South America Personal Lancets, by Type USD Million (2018-2023)
  • Table 21. South America Personal Lancets, by Application USD Million (2018-2023)
  • Table 22. South America Personal Lancets, by Distribution Channel USD Million (2018-2023)
  • Table 23. South America Personal Lancets, by Material Type USD Million (2018-2023)
  • Table 24. Brazil Personal Lancets, by Type USD Million (2018-2023)
  • Table 25. Brazil Personal Lancets, by Application USD Million (2018-2023)
  • Table 26. Brazil Personal Lancets, by Distribution Channel USD Million (2018-2023)
  • Table 27. Brazil Personal Lancets, by Material Type USD Million (2018-2023)
  • Table 28. Argentina Personal Lancets, by Type USD Million (2018-2023)
  • Table 29. Argentina Personal Lancets, by Application USD Million (2018-2023)
  • Table 30. Argentina Personal Lancets, by Distribution Channel USD Million (2018-2023)
  • Table 31. Argentina Personal Lancets, by Material Type USD Million (2018-2023)
  • Table 32. Rest of South America Personal Lancets, by Type USD Million (2018-2023)
  • Table 33. Rest of South America Personal Lancets, by Application USD Million (2018-2023)
  • Table 34. Rest of South America Personal Lancets, by Distribution Channel USD Million (2018-2023)
  • Table 35. Rest of South America Personal Lancets, by Material Type USD Million (2018-2023)
  • Table 36. Asia Pacific Personal Lancets, by Country USD Million (2018-2023)
  • Table 37. Asia Pacific Personal Lancets, by Type USD Million (2018-2023)
  • Table 38. Asia Pacific Personal Lancets, by Application USD Million (2018-2023)
  • Table 39. Asia Pacific Personal Lancets, by Distribution Channel USD Million (2018-2023)
  • Table 40. Asia Pacific Personal Lancets, by Material Type USD Million (2018-2023)
  • Table 41. China Personal Lancets, by Type USD Million (2018-2023)
  • Table 42. China Personal Lancets, by Application USD Million (2018-2023)
  • Table 43. China Personal Lancets, by Distribution Channel USD Million (2018-2023)
  • Table 44. China Personal Lancets, by Material Type USD Million (2018-2023)
  • Table 45. Japan Personal Lancets, by Type USD Million (2018-2023)
  • Table 46. Japan Personal Lancets, by Application USD Million (2018-2023)
  • Table 47. Japan Personal Lancets, by Distribution Channel USD Million (2018-2023)
  • Table 48. Japan Personal Lancets, by Material Type USD Million (2018-2023)
  • Table 49. India Personal Lancets, by Type USD Million (2018-2023)
  • Table 50. India Personal Lancets, by Application USD Million (2018-2023)
  • Table 51. India Personal Lancets, by Distribution Channel USD Million (2018-2023)
  • Table 52. India Personal Lancets, by Material Type USD Million (2018-2023)
  • Table 53. South Korea Personal Lancets, by Type USD Million (2018-2023)
  • Table 54. South Korea Personal Lancets, by Application USD Million (2018-2023)
  • Table 55. South Korea Personal Lancets, by Distribution Channel USD Million (2018-2023)
  • Table 56. South Korea Personal Lancets, by Material Type USD Million (2018-2023)
  • Table 57. Taiwan Personal Lancets, by Type USD Million (2018-2023)
  • Table 58. Taiwan Personal Lancets, by Application USD Million (2018-2023)
  • Table 59. Taiwan Personal Lancets, by Distribution Channel USD Million (2018-2023)
  • Table 60. Taiwan Personal Lancets, by Material Type USD Million (2018-2023)
  • Table 61. Australia Personal Lancets, by Type USD Million (2018-2023)
  • Table 62. Australia Personal Lancets, by Application USD Million (2018-2023)
  • Table 63. Australia Personal Lancets, by Distribution Channel USD Million (2018-2023)
  • Table 64. Australia Personal Lancets, by Material Type USD Million (2018-2023)
  • Table 65. Rest of Asia-Pacific Personal Lancets, by Type USD Million (2018-2023)
  • Table 66. Rest of Asia-Pacific Personal Lancets, by Application USD Million (2018-2023)
  • Table 67. Rest of Asia-Pacific Personal Lancets, by Distribution Channel USD Million (2018-2023)
  • Table 68. Rest of Asia-Pacific Personal Lancets, by Material Type USD Million (2018-2023)
  • Table 69. Europe Personal Lancets, by Country USD Million (2018-2023)
  • Table 70. Europe Personal Lancets, by Type USD Million (2018-2023)
  • Table 71. Europe Personal Lancets, by Application USD Million (2018-2023)
  • Table 72. Europe Personal Lancets, by Distribution Channel USD Million (2018-2023)
  • Table 73. Europe Personal Lancets, by Material Type USD Million (2018-2023)
  • Table 74. Germany Personal Lancets, by Type USD Million (2018-2023)
  • Table 75. Germany Personal Lancets, by Application USD Million (2018-2023)
  • Table 76. Germany Personal Lancets, by Distribution Channel USD Million (2018-2023)
  • Table 77. Germany Personal Lancets, by Material Type USD Million (2018-2023)
  • Table 78. France Personal Lancets, by Type USD Million (2018-2023)
  • Table 79. France Personal Lancets, by Application USD Million (2018-2023)
  • Table 80. France Personal Lancets, by Distribution Channel USD Million (2018-2023)
  • Table 81. France Personal Lancets, by Material Type USD Million (2018-2023)
  • Table 82. Italy Personal Lancets, by Type USD Million (2018-2023)
  • Table 83. Italy Personal Lancets, by Application USD Million (2018-2023)
  • Table 84. Italy Personal Lancets, by Distribution Channel USD Million (2018-2023)
  • Table 85. Italy Personal Lancets, by Material Type USD Million (2018-2023)
  • Table 86. United Kingdom Personal Lancets, by Type USD Million (2018-2023)
  • Table 87. United Kingdom Personal Lancets, by Application USD Million (2018-2023)
  • Table 88. United Kingdom Personal Lancets, by Distribution Channel USD Million (2018-2023)
  • Table 89. United Kingdom Personal Lancets, by Material Type USD Million (2018-2023)
  • Table 90. Netherlands Personal Lancets, by Type USD Million (2018-2023)
  • Table 91. Netherlands Personal Lancets, by Application USD Million (2018-2023)
  • Table 92. Netherlands Personal Lancets, by Distribution Channel USD Million (2018-2023)
  • Table 93. Netherlands Personal Lancets, by Material Type USD Million (2018-2023)
  • Table 94. Rest of Europe Personal Lancets, by Type USD Million (2018-2023)
  • Table 95. Rest of Europe Personal Lancets, by Application USD Million (2018-2023)
  • Table 96. Rest of Europe Personal Lancets, by Distribution Channel USD Million (2018-2023)
  • Table 97. Rest of Europe Personal Lancets, by Material Type USD Million (2018-2023)
  • Table 98. MEA Personal Lancets, by Country USD Million (2018-2023)
  • Table 99. MEA Personal Lancets, by Type USD Million (2018-2023)
  • Table 100. MEA Personal Lancets, by Application USD Million (2018-2023)
  • Table 101. MEA Personal Lancets, by Distribution Channel USD Million (2018-2023)
  • Table 102. MEA Personal Lancets, by Material Type USD Million (2018-2023)
  • Table 103. Middle East Personal Lancets, by Type USD Million (2018-2023)
  • Table 104. Middle East Personal Lancets, by Application USD Million (2018-2023)
  • Table 105. Middle East Personal Lancets, by Distribution Channel USD Million (2018-2023)
  • Table 106. Middle East Personal Lancets, by Material Type USD Million (2018-2023)
  • Table 107. Africa Personal Lancets, by Type USD Million (2018-2023)
  • Table 108. Africa Personal Lancets, by Application USD Million (2018-2023)
  • Table 109. Africa Personal Lancets, by Distribution Channel USD Million (2018-2023)
  • Table 110. Africa Personal Lancets, by Material Type USD Million (2018-2023)
  • Table 111. North America Personal Lancets, by Country USD Million (2018-2023)
  • Table 112. North America Personal Lancets, by Type USD Million (2018-2023)
  • Table 113. North America Personal Lancets, by Application USD Million (2018-2023)
  • Table 114. North America Personal Lancets, by Distribution Channel USD Million (2018-2023)
  • Table 115. North America Personal Lancets, by Material Type USD Million (2018-2023)
  • Table 116. United States Personal Lancets, by Type USD Million (2018-2023)
  • Table 117. United States Personal Lancets, by Application USD Million (2018-2023)
  • Table 118. United States Personal Lancets, by Distribution Channel USD Million (2018-2023)
  • Table 119. United States Personal Lancets, by Material Type USD Million (2018-2023)
  • Table 120. Canada Personal Lancets, by Type USD Million (2018-2023)
  • Table 121. Canada Personal Lancets, by Application USD Million (2018-2023)
  • Table 122. Canada Personal Lancets, by Distribution Channel USD Million (2018-2023)
  • Table 123. Canada Personal Lancets, by Material Type USD Million (2018-2023)
  • Table 124. Mexico Personal Lancets, by Type USD Million (2018-2023)
  • Table 125. Mexico Personal Lancets, by Application USD Million (2018-2023)
  • Table 126. Mexico Personal Lancets, by Distribution Channel USD Million (2018-2023)
  • Table 127. Mexico Personal Lancets, by Material Type USD Million (2018-2023)
  • Table 128. Personal Lancets Sales: by Type(K Units)
  • Table 129. Personal Lancets Sales 21G , by Region K Units (2018-2023)
  • Table 130. Personal Lancets Sales 26G , by Region K Units (2018-2023)
  • Table 131. Personal Lancets Sales 28G , by Region K Units (2018-2023)
  • Table 132. Personal Lancets Sales 30G , by Region K Units (2018-2023)
  • Table 133. Personal Lancets Sales 33G , by Region K Units (2018-2023)
  • Table 134. Personal Lancets Sales Others , by Region K Units (2018-2023)
  • Table 135. Personal Lancets Sales: by Application(K Units)
  • Table 136. Personal Lancets Sales Glucose Testing , by Region K Units (2018-2023)
  • Table 137. Personal Lancets Sales Hemoglobin Testing , by Region K Units (2018-2023)
  • Table 138. Personal Lancets Sales Coagulation Testing , by Region K Units (2018-2023)
  • Table 139. Personal Lancets Sales Other Applications , by Region K Units (2018-2023)
  • Table 140. Personal Lancets Sales: by Distribution Channel(K Units)
  • Table 141. Personal Lancets Sales Online , by Region K Units (2018-2023)
  • Table 142. Personal Lancets Sales Offline , by Region K Units (2018-2023)
  • Table 143. Personal Lancets Sales: by Material Type(K Units)
  • Table 144. Personal Lancets Sales Natural Plastic , by Region K Units (2018-2023)
  • Table 145. Personal Lancets Sales Latex-Free Plastic , by Region K Units (2018-2023)
  • Table 146. South America Personal Lancets Sales, by Country K Units (2018-2023)
  • Table 147. South America Personal Lancets Sales, by Type K Units (2018-2023)
  • Table 148. South America Personal Lancets Sales, by Application K Units (2018-2023)
  • Table 149. South America Personal Lancets Sales, by Distribution Channel K Units (2018-2023)
  • Table 150. South America Personal Lancets Sales, by Material Type K Units (2018-2023)
  • Table 151. Brazil Personal Lancets Sales, by Type K Units (2018-2023)
  • Table 152. Brazil Personal Lancets Sales, by Application K Units (2018-2023)
  • Table 153. Brazil Personal Lancets Sales, by Distribution Channel K Units (2018-2023)
  • Table 154. Brazil Personal Lancets Sales, by Material Type K Units (2018-2023)
  • Table 155. Argentina Personal Lancets Sales, by Type K Units (2018-2023)
  • Table 156. Argentina Personal Lancets Sales, by Application K Units (2018-2023)
  • Table 157. Argentina Personal Lancets Sales, by Distribution Channel K Units (2018-2023)
  • Table 158. Argentina Personal Lancets Sales, by Material Type K Units (2018-2023)
  • Table 159. Rest of South America Personal Lancets Sales, by Type K Units (2018-2023)
  • Table 160. Rest of South America Personal Lancets Sales, by Application K Units (2018-2023)
  • Table 161. Rest of South America Personal Lancets Sales, by Distribution Channel K Units (2018-2023)
  • Table 162. Rest of South America Personal Lancets Sales, by Material Type K Units (2018-2023)
  • Table 163. Asia Pacific Personal Lancets Sales, by Country K Units (2018-2023)
  • Table 164. Asia Pacific Personal Lancets Sales, by Type K Units (2018-2023)
  • Table 165. Asia Pacific Personal Lancets Sales, by Application K Units (2018-2023)
  • Table 166. Asia Pacific Personal Lancets Sales, by Distribution Channel K Units (2018-2023)
  • Table 167. Asia Pacific Personal Lancets Sales, by Material Type K Units (2018-2023)
  • Table 168. China Personal Lancets Sales, by Type K Units (2018-2023)
  • Table 169. China Personal Lancets Sales, by Application K Units (2018-2023)
  • Table 170. China Personal Lancets Sales, by Distribution Channel K Units (2018-2023)
  • Table 171. China Personal Lancets Sales, by Material Type K Units (2018-2023)
  • Table 172. Japan Personal Lancets Sales, by Type K Units (2018-2023)
  • Table 173. Japan Personal Lancets Sales, by Application K Units (2018-2023)
  • Table 174. Japan Personal Lancets Sales, by Distribution Channel K Units (2018-2023)
  • Table 175. Japan Personal Lancets Sales, by Material Type K Units (2018-2023)
  • Table 176. India Personal Lancets Sales, by Type K Units (2018-2023)
  • Table 177. India Personal Lancets Sales, by Application K Units (2018-2023)
  • Table 178. India Personal Lancets Sales, by Distribution Channel K Units (2018-2023)
  • Table 179. India Personal Lancets Sales, by Material Type K Units (2018-2023)
  • Table 180. South Korea Personal Lancets Sales, by Type K Units (2018-2023)
  • Table 181. South Korea Personal Lancets Sales, by Application K Units (2018-2023)
  • Table 182. South Korea Personal Lancets Sales, by Distribution Channel K Units (2018-2023)
  • Table 183. South Korea Personal Lancets Sales, by Material Type K Units (2018-2023)
  • Table 184. Taiwan Personal Lancets Sales, by Type K Units (2018-2023)
  • Table 185. Taiwan Personal Lancets Sales, by Application K Units (2018-2023)
  • Table 186. Taiwan Personal Lancets Sales, by Distribution Channel K Units (2018-2023)
  • Table 187. Taiwan Personal Lancets Sales, by Material Type K Units (2018-2023)
  • Table 188. Australia Personal Lancets Sales, by Type K Units (2018-2023)
  • Table 189. Australia Personal Lancets Sales, by Application K Units (2018-2023)
  • Table 190. Australia Personal Lancets Sales, by Distribution Channel K Units (2018-2023)
  • Table 191. Australia Personal Lancets Sales, by Material Type K Units (2018-2023)
  • Table 192. Rest of Asia-Pacific Personal Lancets Sales, by Type K Units (2018-2023)
  • Table 193. Rest of Asia-Pacific Personal Lancets Sales, by Application K Units (2018-2023)
  • Table 194. Rest of Asia-Pacific Personal Lancets Sales, by Distribution Channel K Units (2018-2023)
  • Table 195. Rest of Asia-Pacific Personal Lancets Sales, by Material Type K Units (2018-2023)
  • Table 196. Europe Personal Lancets Sales, by Country K Units (2018-2023)
  • Table 197. Europe Personal Lancets Sales, by Type K Units (2018-2023)
  • Table 198. Europe Personal Lancets Sales, by Application K Units (2018-2023)
  • Table 199. Europe Personal Lancets Sales, by Distribution Channel K Units (2018-2023)
  • Table 200. Europe Personal Lancets Sales, by Material Type K Units (2018-2023)
  • Table 201. Germany Personal Lancets Sales, by Type K Units (2018-2023)
  • Table 202. Germany Personal Lancets Sales, by Application K Units (2018-2023)
  • Table 203. Germany Personal Lancets Sales, by Distribution Channel K Units (2018-2023)
  • Table 204. Germany Personal Lancets Sales, by Material Type K Units (2018-2023)
  • Table 205. France Personal Lancets Sales, by Type K Units (2018-2023)
  • Table 206. France Personal Lancets Sales, by Application K Units (2018-2023)
  • Table 207. France Personal Lancets Sales, by Distribution Channel K Units (2018-2023)
  • Table 208. France Personal Lancets Sales, by Material Type K Units (2018-2023)
  • Table 209. Italy Personal Lancets Sales, by Type K Units (2018-2023)
  • Table 210. Italy Personal Lancets Sales, by Application K Units (2018-2023)
  • Table 211. Italy Personal Lancets Sales, by Distribution Channel K Units (2018-2023)
  • Table 212. Italy Personal Lancets Sales, by Material Type K Units (2018-2023)
  • Table 213. United Kingdom Personal Lancets Sales, by Type K Units (2018-2023)
  • Table 214. United Kingdom Personal Lancets Sales, by Application K Units (2018-2023)
  • Table 215. United Kingdom Personal Lancets Sales, by Distribution Channel K Units (2018-2023)
  • Table 216. United Kingdom Personal Lancets Sales, by Material Type K Units (2018-2023)
  • Table 217. Netherlands Personal Lancets Sales, by Type K Units (2018-2023)
  • Table 218. Netherlands Personal Lancets Sales, by Application K Units (2018-2023)
  • Table 219. Netherlands Personal Lancets Sales, by Distribution Channel K Units (2018-2023)
  • Table 220. Netherlands Personal Lancets Sales, by Material Type K Units (2018-2023)
  • Table 221. Rest of Europe Personal Lancets Sales, by Type K Units (2018-2023)
  • Table 222. Rest of Europe Personal Lancets Sales, by Application K Units (2018-2023)
  • Table 223. Rest of Europe Personal Lancets Sales, by Distribution Channel K Units (2018-2023)
  • Table 224. Rest of Europe Personal Lancets Sales, by Material Type K Units (2018-2023)
  • Table 225. MEA Personal Lancets Sales, by Country K Units (2018-2023)
  • Table 226. MEA Personal Lancets Sales, by Type K Units (2018-2023)
  • Table 227. MEA Personal Lancets Sales, by Application K Units (2018-2023)
  • Table 228. MEA Personal Lancets Sales, by Distribution Channel K Units (2018-2023)
  • Table 229. MEA Personal Lancets Sales, by Material Type K Units (2018-2023)
  • Table 230. Middle East Personal Lancets Sales, by Type K Units (2018-2023)
  • Table 231. Middle East Personal Lancets Sales, by Application K Units (2018-2023)
  • Table 232. Middle East Personal Lancets Sales, by Distribution Channel K Units (2018-2023)
  • Table 233. Middle East Personal Lancets Sales, by Material Type K Units (2018-2023)
  • Table 234. Africa Personal Lancets Sales, by Type K Units (2018-2023)
  • Table 235. Africa Personal Lancets Sales, by Application K Units (2018-2023)
  • Table 236. Africa Personal Lancets Sales, by Distribution Channel K Units (2018-2023)
  • Table 237. Africa Personal Lancets Sales, by Material Type K Units (2018-2023)
  • Table 238. North America Personal Lancets Sales, by Country K Units (2018-2023)
  • Table 239. North America Personal Lancets Sales, by Type K Units (2018-2023)
  • Table 240. North America Personal Lancets Sales, by Application K Units (2018-2023)
  • Table 241. North America Personal Lancets Sales, by Distribution Channel K Units (2018-2023)
  • Table 242. North America Personal Lancets Sales, by Material Type K Units (2018-2023)
  • Table 243. United States Personal Lancets Sales, by Type K Units (2018-2023)
  • Table 244. United States Personal Lancets Sales, by Application K Units (2018-2023)
  • Table 245. United States Personal Lancets Sales, by Distribution Channel K Units (2018-2023)
  • Table 246. United States Personal Lancets Sales, by Material Type K Units (2018-2023)
  • Table 247. Canada Personal Lancets Sales, by Type K Units (2018-2023)
  • Table 248. Canada Personal Lancets Sales, by Application K Units (2018-2023)
  • Table 249. Canada Personal Lancets Sales, by Distribution Channel K Units (2018-2023)
  • Table 250. Canada Personal Lancets Sales, by Material Type K Units (2018-2023)
  • Table 251. Mexico Personal Lancets Sales, by Type K Units (2018-2023)
  • Table 252. Mexico Personal Lancets Sales, by Application K Units (2018-2023)
  • Table 253. Mexico Personal Lancets Sales, by Distribution Channel K Units (2018-2023)
  • Table 254. Mexico Personal Lancets Sales, by Material Type K Units (2018-2023)
  • Table 255. Personal Lancets: by Type(USD/Units)
  • Table 256. Company Basic Information, Sales Area and Its Competitors
  • Table 257. Company Basic Information, Sales Area and Its Competitors
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Company Basic Information, Sales Area and Its Competitors
  • Table 260. Company Basic Information, Sales Area and Its Competitors
  • Table 261. Company Basic Information, Sales Area and Its Competitors
  • Table 262. Company Basic Information, Sales Area and Its Competitors
  • Table 263. Company Basic Information, Sales Area and Its Competitors
  • Table 264. Personal Lancets: by Type(USD Million)
  • Table 265. Personal Lancets 21G , by Region USD Million (2025-2030)
  • Table 266. Personal Lancets 26G , by Region USD Million (2025-2030)
  • Table 267. Personal Lancets 28G , by Region USD Million (2025-2030)
  • Table 268. Personal Lancets 30G , by Region USD Million (2025-2030)
  • Table 269. Personal Lancets 33G , by Region USD Million (2025-2030)
  • Table 270. Personal Lancets Others , by Region USD Million (2025-2030)
  • Table 271. Personal Lancets: by Application(USD Million)
  • Table 272. Personal Lancets Glucose Testing , by Region USD Million (2025-2030)
  • Table 273. Personal Lancets Hemoglobin Testing , by Region USD Million (2025-2030)
  • Table 274. Personal Lancets Coagulation Testing , by Region USD Million (2025-2030)
  • Table 275. Personal Lancets Other Applications , by Region USD Million (2025-2030)
  • Table 276. Personal Lancets: by Distribution Channel(USD Million)
  • Table 277. Personal Lancets Online , by Region USD Million (2025-2030)
  • Table 278. Personal Lancets Offline , by Region USD Million (2025-2030)
  • Table 279. Personal Lancets: by Material Type(USD Million)
  • Table 280. Personal Lancets Natural Plastic , by Region USD Million (2025-2030)
  • Table 281. Personal Lancets Latex-Free Plastic , by Region USD Million (2025-2030)
  • Table 282. South America Personal Lancets, by Country USD Million (2025-2030)
  • Table 283. South America Personal Lancets, by Type USD Million (2025-2030)
  • Table 284. South America Personal Lancets, by Application USD Million (2025-2030)
  • Table 285. South America Personal Lancets, by Distribution Channel USD Million (2025-2030)
  • Table 286. South America Personal Lancets, by Material Type USD Million (2025-2030)
  • Table 287. Brazil Personal Lancets, by Type USD Million (2025-2030)
  • Table 288. Brazil Personal Lancets, by Application USD Million (2025-2030)
  • Table 289. Brazil Personal Lancets, by Distribution Channel USD Million (2025-2030)
  • Table 290. Brazil Personal Lancets, by Material Type USD Million (2025-2030)
  • Table 291. Argentina Personal Lancets, by Type USD Million (2025-2030)
  • Table 292. Argentina Personal Lancets, by Application USD Million (2025-2030)
  • Table 293. Argentina Personal Lancets, by Distribution Channel USD Million (2025-2030)
  • Table 294. Argentina Personal Lancets, by Material Type USD Million (2025-2030)
  • Table 295. Rest of South America Personal Lancets, by Type USD Million (2025-2030)
  • Table 296. Rest of South America Personal Lancets, by Application USD Million (2025-2030)
  • Table 297. Rest of South America Personal Lancets, by Distribution Channel USD Million (2025-2030)
  • Table 298. Rest of South America Personal Lancets, by Material Type USD Million (2025-2030)
  • Table 299. Asia Pacific Personal Lancets, by Country USD Million (2025-2030)
  • Table 300. Asia Pacific Personal Lancets, by Type USD Million (2025-2030)
  • Table 301. Asia Pacific Personal Lancets, by Application USD Million (2025-2030)
  • Table 302. Asia Pacific Personal Lancets, by Distribution Channel USD Million (2025-2030)
  • Table 303. Asia Pacific Personal Lancets, by Material Type USD Million (2025-2030)
  • Table 304. China Personal Lancets, by Type USD Million (2025-2030)
  • Table 305. China Personal Lancets, by Application USD Million (2025-2030)
  • Table 306. China Personal Lancets, by Distribution Channel USD Million (2025-2030)
  • Table 307. China Personal Lancets, by Material Type USD Million (2025-2030)
  • Table 308. Japan Personal Lancets, by Type USD Million (2025-2030)
  • Table 309. Japan Personal Lancets, by Application USD Million (2025-2030)
  • Table 310. Japan Personal Lancets, by Distribution Channel USD Million (2025-2030)
  • Table 311. Japan Personal Lancets, by Material Type USD Million (2025-2030)
  • Table 312. India Personal Lancets, by Type USD Million (2025-2030)
  • Table 313. India Personal Lancets, by Application USD Million (2025-2030)
  • Table 314. India Personal Lancets, by Distribution Channel USD Million (2025-2030)
  • Table 315. India Personal Lancets, by Material Type USD Million (2025-2030)
  • Table 316. South Korea Personal Lancets, by Type USD Million (2025-2030)
  • Table 317. South Korea Personal Lancets, by Application USD Million (2025-2030)
  • Table 318. South Korea Personal Lancets, by Distribution Channel USD Million (2025-2030)
  • Table 319. South Korea Personal Lancets, by Material Type USD Million (2025-2030)
  • Table 320. Taiwan Personal Lancets, by Type USD Million (2025-2030)
  • Table 321. Taiwan Personal Lancets, by Application USD Million (2025-2030)
  • Table 322. Taiwan Personal Lancets, by Distribution Channel USD Million (2025-2030)
  • Table 323. Taiwan Personal Lancets, by Material Type USD Million (2025-2030)
  • Table 324. Australia Personal Lancets, by Type USD Million (2025-2030)
  • Table 325. Australia Personal Lancets, by Application USD Million (2025-2030)
  • Table 326. Australia Personal Lancets, by Distribution Channel USD Million (2025-2030)
  • Table 327. Australia Personal Lancets, by Material Type USD Million (2025-2030)
  • Table 328. Rest of Asia-Pacific Personal Lancets, by Type USD Million (2025-2030)
  • Table 329. Rest of Asia-Pacific Personal Lancets, by Application USD Million (2025-2030)
  • Table 330. Rest of Asia-Pacific Personal Lancets, by Distribution Channel USD Million (2025-2030)
  • Table 331. Rest of Asia-Pacific Personal Lancets, by Material Type USD Million (2025-2030)
  • Table 332. Europe Personal Lancets, by Country USD Million (2025-2030)
  • Table 333. Europe Personal Lancets, by Type USD Million (2025-2030)
  • Table 334. Europe Personal Lancets, by Application USD Million (2025-2030)
  • Table 335. Europe Personal Lancets, by Distribution Channel USD Million (2025-2030)
  • Table 336. Europe Personal Lancets, by Material Type USD Million (2025-2030)
  • Table 337. Germany Personal Lancets, by Type USD Million (2025-2030)
  • Table 338. Germany Personal Lancets, by Application USD Million (2025-2030)
  • Table 339. Germany Personal Lancets, by Distribution Channel USD Million (2025-2030)
  • Table 340. Germany Personal Lancets, by Material Type USD Million (2025-2030)
  • Table 341. France Personal Lancets, by Type USD Million (2025-2030)
  • Table 342. France Personal Lancets, by Application USD Million (2025-2030)
  • Table 343. France Personal Lancets, by Distribution Channel USD Million (2025-2030)
  • Table 344. France Personal Lancets, by Material Type USD Million (2025-2030)
  • Table 345. Italy Personal Lancets, by Type USD Million (2025-2030)
  • Table 346. Italy Personal Lancets, by Application USD Million (2025-2030)
  • Table 347. Italy Personal Lancets, by Distribution Channel USD Million (2025-2030)
  • Table 348. Italy Personal Lancets, by Material Type USD Million (2025-2030)
  • Table 349. United Kingdom Personal Lancets, by Type USD Million (2025-2030)
  • Table 350. United Kingdom Personal Lancets, by Application USD Million (2025-2030)
  • Table 351. United Kingdom Personal Lancets, by Distribution Channel USD Million (2025-2030)
  • Table 352. United Kingdom Personal Lancets, by Material Type USD Million (2025-2030)
  • Table 353. Netherlands Personal Lancets, by Type USD Million (2025-2030)
  • Table 354. Netherlands Personal Lancets, by Application USD Million (2025-2030)
  • Table 355. Netherlands Personal Lancets, by Distribution Channel USD Million (2025-2030)
  • Table 356. Netherlands Personal Lancets, by Material Type USD Million (2025-2030)
  • Table 357. Rest of Europe Personal Lancets, by Type USD Million (2025-2030)
  • Table 358. Rest of Europe Personal Lancets, by Application USD Million (2025-2030)
  • Table 359. Rest of Europe Personal Lancets, by Distribution Channel USD Million (2025-2030)
  • Table 360. Rest of Europe Personal Lancets, by Material Type USD Million (2025-2030)
  • Table 361. MEA Personal Lancets, by Country USD Million (2025-2030)
  • Table 362. MEA Personal Lancets, by Type USD Million (2025-2030)
  • Table 363. MEA Personal Lancets, by Application USD Million (2025-2030)
  • Table 364. MEA Personal Lancets, by Distribution Channel USD Million (2025-2030)
  • Table 365. MEA Personal Lancets, by Material Type USD Million (2025-2030)
  • Table 366. Middle East Personal Lancets, by Type USD Million (2025-2030)
  • Table 367. Middle East Personal Lancets, by Application USD Million (2025-2030)
  • Table 368. Middle East Personal Lancets, by Distribution Channel USD Million (2025-2030)
  • Table 369. Middle East Personal Lancets, by Material Type USD Million (2025-2030)
  • Table 370. Africa Personal Lancets, by Type USD Million (2025-2030)
  • Table 371. Africa Personal Lancets, by Application USD Million (2025-2030)
  • Table 372. Africa Personal Lancets, by Distribution Channel USD Million (2025-2030)
  • Table 373. Africa Personal Lancets, by Material Type USD Million (2025-2030)
  • Table 374. North America Personal Lancets, by Country USD Million (2025-2030)
  • Table 375. North America Personal Lancets, by Type USD Million (2025-2030)
  • Table 376. North America Personal Lancets, by Application USD Million (2025-2030)
  • Table 377. North America Personal Lancets, by Distribution Channel USD Million (2025-2030)
  • Table 378. North America Personal Lancets, by Material Type USD Million (2025-2030)
  • Table 379. United States Personal Lancets, by Type USD Million (2025-2030)
  • Table 380. United States Personal Lancets, by Application USD Million (2025-2030)
  • Table 381. United States Personal Lancets, by Distribution Channel USD Million (2025-2030)
  • Table 382. United States Personal Lancets, by Material Type USD Million (2025-2030)
  • Table 383. Canada Personal Lancets, by Type USD Million (2025-2030)
  • Table 384. Canada Personal Lancets, by Application USD Million (2025-2030)
  • Table 385. Canada Personal Lancets, by Distribution Channel USD Million (2025-2030)
  • Table 386. Canada Personal Lancets, by Material Type USD Million (2025-2030)
  • Table 387. Mexico Personal Lancets, by Type USD Million (2025-2030)
  • Table 388. Mexico Personal Lancets, by Application USD Million (2025-2030)
  • Table 389. Mexico Personal Lancets, by Distribution Channel USD Million (2025-2030)
  • Table 390. Mexico Personal Lancets, by Material Type USD Million (2025-2030)
  • Table 391. Personal Lancets Sales: by Type(K Units)
  • Table 392. Personal Lancets Sales 21G , by Region K Units (2025-2030)
  • Table 393. Personal Lancets Sales 26G , by Region K Units (2025-2030)
  • Table 394. Personal Lancets Sales 28G , by Region K Units (2025-2030)
  • Table 395. Personal Lancets Sales 30G , by Region K Units (2025-2030)
  • Table 396. Personal Lancets Sales 33G , by Region K Units (2025-2030)
  • Table 397. Personal Lancets Sales Others , by Region K Units (2025-2030)
  • Table 398. Personal Lancets Sales: by Application(K Units)
  • Table 399. Personal Lancets Sales Glucose Testing , by Region K Units (2025-2030)
  • Table 400. Personal Lancets Sales Hemoglobin Testing , by Region K Units (2025-2030)
  • Table 401. Personal Lancets Sales Coagulation Testing , by Region K Units (2025-2030)
  • Table 402. Personal Lancets Sales Other Applications , by Region K Units (2025-2030)
  • Table 403. Personal Lancets Sales: by Distribution Channel(K Units)
  • Table 404. Personal Lancets Sales Online , by Region K Units (2025-2030)
  • Table 405. Personal Lancets Sales Offline , by Region K Units (2025-2030)
  • Table 406. Personal Lancets Sales: by Material Type(K Units)
  • Table 407. Personal Lancets Sales Natural Plastic , by Region K Units (2025-2030)
  • Table 408. Personal Lancets Sales Latex-Free Plastic , by Region K Units (2025-2030)
  • Table 409. South America Personal Lancets Sales, by Country K Units (2025-2030)
  • Table 410. South America Personal Lancets Sales, by Type K Units (2025-2030)
  • Table 411. South America Personal Lancets Sales, by Application K Units (2025-2030)
  • Table 412. South America Personal Lancets Sales, by Distribution Channel K Units (2025-2030)
  • Table 413. South America Personal Lancets Sales, by Material Type K Units (2025-2030)
  • Table 414. Brazil Personal Lancets Sales, by Type K Units (2025-2030)
  • Table 415. Brazil Personal Lancets Sales, by Application K Units (2025-2030)
  • Table 416. Brazil Personal Lancets Sales, by Distribution Channel K Units (2025-2030)
  • Table 417. Brazil Personal Lancets Sales, by Material Type K Units (2025-2030)
  • Table 418. Argentina Personal Lancets Sales, by Type K Units (2025-2030)
  • Table 419. Argentina Personal Lancets Sales, by Application K Units (2025-2030)
  • Table 420. Argentina Personal Lancets Sales, by Distribution Channel K Units (2025-2030)
  • Table 421. Argentina Personal Lancets Sales, by Material Type K Units (2025-2030)
  • Table 422. Rest of South America Personal Lancets Sales, by Type K Units (2025-2030)
  • Table 423. Rest of South America Personal Lancets Sales, by Application K Units (2025-2030)
  • Table 424. Rest of South America Personal Lancets Sales, by Distribution Channel K Units (2025-2030)
  • Table 425. Rest of South America Personal Lancets Sales, by Material Type K Units (2025-2030)
  • Table 426. Asia Pacific Personal Lancets Sales, by Country K Units (2025-2030)
  • Table 427. Asia Pacific Personal Lancets Sales, by Type K Units (2025-2030)
  • Table 428. Asia Pacific Personal Lancets Sales, by Application K Units (2025-2030)
  • Table 429. Asia Pacific Personal Lancets Sales, by Distribution Channel K Units (2025-2030)
  • Table 430. Asia Pacific Personal Lancets Sales, by Material Type K Units (2025-2030)
  • Table 431. China Personal Lancets Sales, by Type K Units (2025-2030)
  • Table 432. China Personal Lancets Sales, by Application K Units (2025-2030)
  • Table 433. China Personal Lancets Sales, by Distribution Channel K Units (2025-2030)
  • Table 434. China Personal Lancets Sales, by Material Type K Units (2025-2030)
  • Table 435. Japan Personal Lancets Sales, by Type K Units (2025-2030)
  • Table 436. Japan Personal Lancets Sales, by Application K Units (2025-2030)
  • Table 437. Japan Personal Lancets Sales, by Distribution Channel K Units (2025-2030)
  • Table 438. Japan Personal Lancets Sales, by Material Type K Units (2025-2030)
  • Table 439. India Personal Lancets Sales, by Type K Units (2025-2030)
  • Table 440. India Personal Lancets Sales, by Application K Units (2025-2030)
  • Table 441. India Personal Lancets Sales, by Distribution Channel K Units (2025-2030)
  • Table 442. India Personal Lancets Sales, by Material Type K Units (2025-2030)
  • Table 443. South Korea Personal Lancets Sales, by Type K Units (2025-2030)
  • Table 444. South Korea Personal Lancets Sales, by Application K Units (2025-2030)
  • Table 445. South Korea Personal Lancets Sales, by Distribution Channel K Units (2025-2030)
  • Table 446. South Korea Personal Lancets Sales, by Material Type K Units (2025-2030)
  • Table 447. Taiwan Personal Lancets Sales, by Type K Units (2025-2030)
  • Table 448. Taiwan Personal Lancets Sales, by Application K Units (2025-2030)
  • Table 449. Taiwan Personal Lancets Sales, by Distribution Channel K Units (2025-2030)
  • Table 450. Taiwan Personal Lancets Sales, by Material Type K Units (2025-2030)
  • Table 451. Australia Personal Lancets Sales, by Type K Units (2025-2030)
  • Table 452. Australia Personal Lancets Sales, by Application K Units (2025-2030)
  • Table 453. Australia Personal Lancets Sales, by Distribution Channel K Units (2025-2030)
  • Table 454. Australia Personal Lancets Sales, by Material Type K Units (2025-2030)
  • Table 455. Rest of Asia-Pacific Personal Lancets Sales, by Type K Units (2025-2030)
  • Table 456. Rest of Asia-Pacific Personal Lancets Sales, by Application K Units (2025-2030)
  • Table 457. Rest of Asia-Pacific Personal Lancets Sales, by Distribution Channel K Units (2025-2030)
  • Table 458. Rest of Asia-Pacific Personal Lancets Sales, by Material Type K Units (2025-2030)
  • Table 459. Europe Personal Lancets Sales, by Country K Units (2025-2030)
  • Table 460. Europe Personal Lancets Sales, by Type K Units (2025-2030)
  • Table 461. Europe Personal Lancets Sales, by Application K Units (2025-2030)
  • Table 462. Europe Personal Lancets Sales, by Distribution Channel K Units (2025-2030)
  • Table 463. Europe Personal Lancets Sales, by Material Type K Units (2025-2030)
  • Table 464. Germany Personal Lancets Sales, by Type K Units (2025-2030)
  • Table 465. Germany Personal Lancets Sales, by Application K Units (2025-2030)
  • Table 466. Germany Personal Lancets Sales, by Distribution Channel K Units (2025-2030)
  • Table 467. Germany Personal Lancets Sales, by Material Type K Units (2025-2030)
  • Table 468. France Personal Lancets Sales, by Type K Units (2025-2030)
  • Table 469. France Personal Lancets Sales, by Application K Units (2025-2030)
  • Table 470. France Personal Lancets Sales, by Distribution Channel K Units (2025-2030)
  • Table 471. France Personal Lancets Sales, by Material Type K Units (2025-2030)
  • Table 472. Italy Personal Lancets Sales, by Type K Units (2025-2030)
  • Table 473. Italy Personal Lancets Sales, by Application K Units (2025-2030)
  • Table 474. Italy Personal Lancets Sales, by Distribution Channel K Units (2025-2030)
  • Table 475. Italy Personal Lancets Sales, by Material Type K Units (2025-2030)
  • Table 476. United Kingdom Personal Lancets Sales, by Type K Units (2025-2030)
  • Table 477. United Kingdom Personal Lancets Sales, by Application K Units (2025-2030)
  • Table 478. United Kingdom Personal Lancets Sales, by Distribution Channel K Units (2025-2030)
  • Table 479. United Kingdom Personal Lancets Sales, by Material Type K Units (2025-2030)
  • Table 480. Netherlands Personal Lancets Sales, by Type K Units (2025-2030)
  • Table 481. Netherlands Personal Lancets Sales, by Application K Units (2025-2030)
  • Table 482. Netherlands Personal Lancets Sales, by Distribution Channel K Units (2025-2030)
  • Table 483. Netherlands Personal Lancets Sales, by Material Type K Units (2025-2030)
  • Table 484. Rest of Europe Personal Lancets Sales, by Type K Units (2025-2030)
  • Table 485. Rest of Europe Personal Lancets Sales, by Application K Units (2025-2030)
  • Table 486. Rest of Europe Personal Lancets Sales, by Distribution Channel K Units (2025-2030)
  • Table 487. Rest of Europe Personal Lancets Sales, by Material Type K Units (2025-2030)
  • Table 488. MEA Personal Lancets Sales, by Country K Units (2025-2030)
  • Table 489. MEA Personal Lancets Sales, by Type K Units (2025-2030)
  • Table 490. MEA Personal Lancets Sales, by Application K Units (2025-2030)
  • Table 491. MEA Personal Lancets Sales, by Distribution Channel K Units (2025-2030)
  • Table 492. MEA Personal Lancets Sales, by Material Type K Units (2025-2030)
  • Table 493. Middle East Personal Lancets Sales, by Type K Units (2025-2030)
  • Table 494. Middle East Personal Lancets Sales, by Application K Units (2025-2030)
  • Table 495. Middle East Personal Lancets Sales, by Distribution Channel K Units (2025-2030)
  • Table 496. Middle East Personal Lancets Sales, by Material Type K Units (2025-2030)
  • Table 497. Africa Personal Lancets Sales, by Type K Units (2025-2030)
  • Table 498. Africa Personal Lancets Sales, by Application K Units (2025-2030)
  • Table 499. Africa Personal Lancets Sales, by Distribution Channel K Units (2025-2030)
  • Table 500. Africa Personal Lancets Sales, by Material Type K Units (2025-2030)
  • Table 501. North America Personal Lancets Sales, by Country K Units (2025-2030)
  • Table 502. North America Personal Lancets Sales, by Type K Units (2025-2030)
  • Table 503. North America Personal Lancets Sales, by Application K Units (2025-2030)
  • Table 504. North America Personal Lancets Sales, by Distribution Channel K Units (2025-2030)
  • Table 505. North America Personal Lancets Sales, by Material Type K Units (2025-2030)
  • Table 506. United States Personal Lancets Sales, by Type K Units (2025-2030)
  • Table 507. United States Personal Lancets Sales, by Application K Units (2025-2030)
  • Table 508. United States Personal Lancets Sales, by Distribution Channel K Units (2025-2030)
  • Table 509. United States Personal Lancets Sales, by Material Type K Units (2025-2030)
  • Table 510. Canada Personal Lancets Sales, by Type K Units (2025-2030)
  • Table 511. Canada Personal Lancets Sales, by Application K Units (2025-2030)
  • Table 512. Canada Personal Lancets Sales, by Distribution Channel K Units (2025-2030)
  • Table 513. Canada Personal Lancets Sales, by Material Type K Units (2025-2030)
  • Table 514. Mexico Personal Lancets Sales, by Type K Units (2025-2030)
  • Table 515. Mexico Personal Lancets Sales, by Application K Units (2025-2030)
  • Table 516. Mexico Personal Lancets Sales, by Distribution Channel K Units (2025-2030)
  • Table 517. Mexico Personal Lancets Sales, by Material Type K Units (2025-2030)
  • Table 518. Personal Lancets: by Type(USD/Units)
  • Table 519. Research Programs/Design for This Report
  • Table 520. Key Data Information from Secondary Sources
  • Table 521. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Personal Lancets: by Type USD Million (2018-2023)
  • Figure 5. Global Personal Lancets: by Application USD Million (2018-2023)
  • Figure 6. Global Personal Lancets: by Distribution Channel USD Million (2018-2023)
  • Figure 7. Global Personal Lancets: by Material Type USD Million (2018-2023)
  • Figure 8. South America Personal Lancets Share (%), by Country
  • Figure 9. Asia Pacific Personal Lancets Share (%), by Country
  • Figure 10. Europe Personal Lancets Share (%), by Country
  • Figure 11. MEA Personal Lancets Share (%), by Country
  • Figure 12. North America Personal Lancets Share (%), by Country
  • Figure 13. Global Personal Lancets: by Type K Units (2018-2023)
  • Figure 14. Global Personal Lancets: by Application K Units (2018-2023)
  • Figure 15. Global Personal Lancets: by Distribution Channel K Units (2018-2023)
  • Figure 16. Global Personal Lancets: by Material Type K Units (2018-2023)
  • Figure 17. South America Personal Lancets Share (%), by Country
  • Figure 18. Asia Pacific Personal Lancets Share (%), by Country
  • Figure 19. Europe Personal Lancets Share (%), by Country
  • Figure 20. MEA Personal Lancets Share (%), by Country
  • Figure 21. North America Personal Lancets Share (%), by Country
  • Figure 22. Global Personal Lancets: by Type USD/Units (2018-2023)
  • Figure 23. Global Personal Lancets share by Players 2023 (%)
  • Figure 24. Global Personal Lancets share by Players (Top 3) 2023(%)
  • Figure 25. Global Personal Lancets share by Players (Top 5) 2023(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. Becton, Dickinson, and Company (United States) Revenue, Net Income and Gross profit
  • Figure 28. Becton, Dickinson, and Company (United States) Revenue: by Geography 2023
  • Figure 29. Roche Diagnostics (Switzerland) Revenue, Net Income and Gross profit
  • Figure 30. Roche Diagnostics (Switzerland) Revenue: by Geography 2023
  • Figure 31. Ypsomed (Switzerland) Revenue, Net Income and Gross profit
  • Figure 32. Ypsomed (Switzerland) Revenue: by Geography 2023
  • Figure 33. B. Braun Melsungen (Germany) Revenue, Net Income and Gross profit
  • Figure 34. B. Braun Melsungen (Germany) Revenue: by Geography 2023
  • Figure 35. Terumo Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 36. Terumo Corporation (Japan) Revenue: by Geography 2023
  • Figure 37. Own Mumford (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 38. Own Mumford (United Kingdom) Revenue: by Geography 2023
  • Figure 39. HTL-STREFA S.A (Poland) Revenue, Net Income and Gross profit
  • Figure 40. HTL-STREFA S.A (Poland) Revenue: by Geography 2023
  • Figure 41. ARKRAY (Japan) Revenue, Net Income and Gross profit
  • Figure 42. ARKRAY (Japan) Revenue: by Geography 2023
  • Figure 43. Global Personal Lancets: by Type USD Million (2025-2030)
  • Figure 44. Global Personal Lancets: by Application USD Million (2025-2030)
  • Figure 45. Global Personal Lancets: by Distribution Channel USD Million (2025-2030)
  • Figure 46. Global Personal Lancets: by Material Type USD Million (2025-2030)
  • Figure 47. South America Personal Lancets Share (%), by Country
  • Figure 48. Asia Pacific Personal Lancets Share (%), by Country
  • Figure 49. Europe Personal Lancets Share (%), by Country
  • Figure 50. MEA Personal Lancets Share (%), by Country
  • Figure 51. North America Personal Lancets Share (%), by Country
  • Figure 52. Global Personal Lancets: by Type K Units (2025-2030)
  • Figure 53. Global Personal Lancets: by Application K Units (2025-2030)
  • Figure 54. Global Personal Lancets: by Distribution Channel K Units (2025-2030)
  • Figure 55. Global Personal Lancets: by Material Type K Units (2025-2030)
  • Figure 56. South America Personal Lancets Share (%), by Country
  • Figure 57. Asia Pacific Personal Lancets Share (%), by Country
  • Figure 58. Europe Personal Lancets Share (%), by Country
  • Figure 59. MEA Personal Lancets Share (%), by Country
  • Figure 60. North America Personal Lancets Share (%), by Country
  • Figure 61. Global Personal Lancets: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Becton, Dickinson, and Company (United States)
  • Roche Diagnostics (Switzerland)
  • Ypsomed (Switzerland)
  • B. Braun Melsungen (Germany)
  • Terumo Corporation (Japan)
  • Own Mumford (United Kingdom)
  • HTL-STREFA S.A (Poland)
  • ARKRAY (Japan)
Additional players considered in the study are as follows:
Sarstedt (Germany) , SteriLance Medical (Suzhou) (China)
Select User Access Type

Key Highlights of Report


Apr 2024 227 Pages 70 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Personal Lancets Market Quantitative research analysis
Global Personal Lancets Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Personal Lancets Market are by type [21G, 26G, 28G, 30G, 33G and Others], by end use application [Glucose Testing, Hemoglobin Testing, Coagulation Testing and Other Applications].
The Personal Lancets Market is gaining popularity and expected to see strong valuation by 2030.
  • Monitoring of diabetes in the diabetic community is one of the main uses or working fields of lancets. According to the Centers for Disease Control and Prevention ( CDC), diabetic patients account for 9.4 percent of the US population. The need for lancets is projected to be tremendous with the growing prevalence of diabetes, resulting in a rising need for diabetes detection and management equipment and products, potentially leading to expanded use of lancets.

Know More About Global Personal Lancets Market Report?

Have a Query? Click Here

Other Related Reports

Ibuprofen Comprehensive Study by Type (USP, EP), Application (Tablet, Capsule, Suspension, Other), End users (Adults, Children) Players and Region - Global Market Outlook to 2030
$ 3500
Vitamin D3 Powder Comprehensive Study by Type (Food Grade , Feed Grade ), Application (Food Industry , Pharmaceuticals Industry , Feed Industry, Beverage, Cosmetics, Other Applications), Source (Eggs...
$ 3450
Adhesive Bandages Comprehensive Study by Type (Flexible Fabric Bandage, Cohesive Fixation Bandage), Indication (Wound Management, Edema Control and Pain Management, Orthopedic Support, Others), Distr...
$ 3750
Denture Products Comprehensive Study by Type (Cleansers, Fixatives, Others), End Users (Dental Hospitals & Clinics, Dental Academic & Research Institutes, Laboratories, Others), Distribution Channel ...
$ 3500
Disposable Medical Gloves Comprehensive Study by Type (Latex Gloves, Nitrile Gloves), Application (Hospitals, Research Laboratories), Form (Powdered Form, Powdered-free Form), Distribution Channel (D...
$ 3750
Eye Care Solution Comprehensive Study by Type (Multipurpose Contact Lens Solution, Hydrogen Peroxide-based Solution), Application (Household, Eyecare Center, Clinics), Packaging (60ml, 100ml, 120ml),...
$ 3450